233 related articles for article (PubMed ID: 2568952)
1. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
[TBL] [Abstract][Full Text] [Related]
2. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
3. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
[TBL] [Abstract][Full Text] [Related]
5. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
Georg A; Friedl A
J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
[TBL] [Abstract][Full Text] [Related]
7. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
DeHaven-Hudkins DL; Fleissner LC
Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
[TBL] [Abstract][Full Text] [Related]
8. Solubilization and characterization of sigma-receptors from guinea pig brain membranes.
Kavanaugh MP; Parker J; Bobker DH; Keana JF; Weber E
J Neurochem; 1989 Nov; 53(5):1575-80. PubMed ID: 2552016
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study.
Walker JM; Bowen WD; Goldstein SR; Roberts AH; Patrick SL; Hohmann AG; DeCosta B
Brain Res; 1992 May; 581(1):33-8. PubMed ID: 1323368
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
Largent BL; Gundlach AL; Snyder SH
J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H] (+)-pentazocine, a highly selective sigma ligand.
Bowen WD; DeCosta B; Hellewell SB; Thurkauf A; Walker JM; Rice KC
Prog Clin Biol Res; 1990; 328():117-20. PubMed ID: 2154763
[No Abstract] [Full Text] [Related]
12. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
Georg A; Friedl A
Glia; 1992; 6(4):258-63. PubMed ID: 1464457
[TBL] [Abstract][Full Text] [Related]
13. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.
Carroll FI; Abraham P; Parham K; Bai X; Zhang X; Brine GA; Mascarella SW; Martin BR; May EL; Sauss C
J Med Chem; 1992 Jul; 35(15):2812-8. PubMed ID: 1322987
[TBL] [Abstract][Full Text] [Related]
14. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
Dumont M; Lemaire S
Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
[TBL] [Abstract][Full Text] [Related]
16. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brain.
Chaki S; Okuyama S; Ogawa S; Tanaka M; Muramatsu M; Nakazato A; Tomisawa K
Life Sci; 1996; 59(16):1331-40. PubMed ID: 8876662
[TBL] [Abstract][Full Text] [Related]
17. Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds.
Hudkins RL; Mailman RB; DeHaven-Hudkins DL
J Med Chem; 1994 Jun; 37(13):1964-70. PubMed ID: 8027978
[TBL] [Abstract][Full Text] [Related]
18. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
19. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
